tiprankstipranks
Trending News
More News >
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market

Pliant Therapeutics (PLRX) Technical Analysis

Compare
509 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Pliant Therapeutics’s (PLRX) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Pliant Therapeutics is a Sell.
Pliant Therapeutics’s (PLRX) 20-Day exponential moving average is 1.47, while Pliant Therapeutics’s (PLRX) share price is $1.63, making it a Buy.
Pliant Therapeutics’s (PLRX) 50-Day exponential moving average is 1.90, while Pliant Therapeutics’s (PLRX) share price is $1.63, making it a Sell.

Pliant Therapeutics (PLRX) Pivot Points

Jun 08, 2025, 12:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.44
1.50
1.55
1.61
1.67
1.73
1.78
Fibonacci
1.50
1.54
1.57
1.61
1.66
1.68
1.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pliant Therapeutics (PLRX) Moving Averages

Jun 08, 2025, 12:52 AM
Period
Simple
Exponential
MA5
1.59Buy
1.58Buy
MA10
1.46Buy
1.51Buy
MA20
1.42Buy
1.47Buy
MA50
1.43Buy
1.90Sell
MA100
3.42Sell
3.71Sell
MA200
8.34Sell
7.27Sell
Pliant Therapeutics’s (PLRX) 10-Day exponential moving average is 1.51, while Pliant Therapeutics’s (PLRX) share price is $1.63, making it a Buy.
Pliant Therapeutics’s (PLRX) 100-Day exponential moving average is 3.71, while Pliant Therapeutics’s (PLRX) share price is $1.63, making it a Sell.
Pliant Therapeutics’s (PLRX) stock price is $1.63 and Pliant Therapeutics’s (PLRX) 50-day simple moving average is 1.43, creating a Buy signal.
Pliant Therapeutics’s (PLRX) stock price is $1.63 and Pliant Therapeutics’s (PLRX) 100-day simple moving average is 3.42, creating a Sell signal.
Pliant Therapeutics’s (PLRX) stock price is $1.63 and Pliant Therapeutics’s (PLRX) 200-day simple moving average is 8.34, creating a Sell signal.

Pliant Therapeutics (PLRX) Technical Indicators

Jun 08, 2025, 12:52 AM
Name
Value
Implied Action
RSI (14)
60.27
Neutral
STOCH (9,6)
87.64
Sell
STOCHRSI (14)
87.64
Sell
MACD (12,26)
0.01
Sell
ADX (14)
22.21
Neutral
Williams %R
-13.68
Sell
CCI (14)
169.10
Sell
ATR (14)
0.12
-
Ultimate Oscillator
59.39
Neutral
ROC
18.12
Buy
Pliant Therapeutics’s (PLRX) Relative Strength Index (RSI) is 60.27, creating a Neutral signal.
Pliant Therapeutics’s (PLRX) Trend Strength Indicator (ADX) is 22.21, creating a Neutral signal.
Pliant Therapeutics’s (PLRX) Commodity Channel Index (CCI) is 169.10, creating a Sell signal.
Pliant Therapeutics’s (PLRX) Price Rate of Change (ROC) is 18.12, creating a Buy signal.

FAQ

Is PLRX a Buy, Hold, or Sell?
Based on PLRX’s technical indicators, PLRX is a Hold.
    What is PLRX’s RSI (14)?
    PLRX’s RSI (14) is 60.27, which suggests PLRX is a Neutral.
      What is PLRX’s MACD?
      PLRX’s MACD is 0.01, which suggests PLRX is a Sell.
        What is PLRX’s 5-day moving average?
        PLRX’s 5-day moving average is 1.59, which suggests PLRX is a Buy.
          What is PLRX’s 20-day moving average?
          PLRX 20-day moving average is 1.42, which suggests PLRX is a Buy.
            What is PLRX’s 50-day moving average?
            PLRX’s 50-day moving average is 1.43, which suggests PLRX is a Buy.
              What is PLRX’s 200-day moving average?
              PLRX’s 200-day moving average is 8.34, which suggests PLRX is a Sell.
                What is PLRX’s Williams % R (14)?
                PLRX’s Williams % R (14) is -13.68, which suggests PLRX is a Sell.
                  What is PLRX’s CCI (14)?
                  PLRX’s CCI (14) is 169.10, which suggests PLRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis